Home/ Crypto News/ Moderna (MRNA) Stock Rockets 177% Following Breakthrough Melanoma Vaccine Results

blockonomi Aug 20, 2026

Moderna (MRNA) Stock Rockets 177% Following Breakthrough Melanoma Vaccine Results

Stocks

Moderna (MRNA) stock skyrocketed 177% Wednesday on Phase III melanoma vaccine success, marking rare S&P 500 doubling day with 491% YTD gains.

The post Moderna (MRNA) Stock Rockets 177% Following Breakthrough Melanoma Vaccine Results appeared first on Blockonomi.

Source: Source: Blockonomi